ABSI vs RLAY
ABSI 与 RLAY 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | ABSIABSCI CORP | RLAYRelay Therapeutics, Inc. |
|---|---|---|
| 市值 | $1.21B | $3.61B |
| 市销率 | 423.7x | 232.2x |
| 营收同比增长 | -38.2% | 53.4% |
| 净利同比增长 | -11.7% | 18.1% |
| 息税前利润率 | -4297.0% | -1971.6% |
| 净资产收益率 | -67.0% | -43.1% |
| 投入资本回报率 | -71.9% | — |
| 一年总回报 | +169.9% | +427.9% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:ABSI vs RLAY
| 指标 | ABSI | RLAY |
|---|---|---|
| 期末价值 | $3.6K | $5.5K |
| 总回报 | -64.0% | -45.0% |
| 年化收益 (CAGR) | -18.4% | -11.2% |
| 波动率 | 98.3% | 78.5% |
| 夏普比率 | 0.24 | 0.18 |
| 索提诺比率 | 0.36 | 0.28 |
| 最大回撤 | -96.2% | -94.7% |
基于 1262 个共同交易日,2021-07-22 → 2026-07-31 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)